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Abstract
Background: The treatment of chronic subdural hematoma (cSDH) is still charged of significant risk of hematoma
recurrence. Patient-related predictors and the surgical procedures themselves have been addressed in many studies. In
contrast, postoperative management has infrequently been subjected to detailed analysis. Moreover variable intravenous
fluid administration (IFA) was not reported in literature till now in the context of cSDH treatment.
Methodology/Principal Findings: A total of 45 patients with cSDH were operated in our department via two burr hole
craniostomy within one calendar year. Downward drainage was routinely left in hematoma cavity for a one day.
Independent variables selected for the analysis were related to various aspects of patient management, including IFA. Two
dependent variables were chosen as measure of clinical course: the rate of hematoma recurrence (RHR) and neurological
status at discharge from hospital expressed in points of Glasgow Outcome Scale (GOS). Univariate and multivariate
regression analyses were performed. Hematoma recurrence with subsequent evacuation occurred in 7 (15%)
patients. Univariate regression analysis revealed that length of IFA after surgery influenced both dependent variables:
RHR (p=0.045) and GOS (p=0.023). Multivariate regression performed by backward elimination method confirmed that IFA
is a sole independent factor influencing RHR. Post hoc dichotomous division of patients revealed that those receiving at
least 2000 ml/day over 3 day period revealed lower RHR than the group with less intensive IFA. (p=0.031).
Conclusions/Significance: IFA has been found to be a sole factor influencing both: RHR and GOS. Based on those results we
may recommend administration of at least 2000 ml per 3 days post-operatively to decrease the risk of hematoma
recurrence.
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Introduction
Nowadays the diagnosis of chronic subdural hematoma (cSDH),
in general, conveys favourable prognosis [1]. It results from
relatively high success rate of surgical treatment. Despite that
cSDH evacuation is charged of significant risk of hematoma
recurrence [2]. Thus the treatment of cSDH still attracts attention
of clinical researchers. It was evinced by controlled randomized
trial published recently in Lancet [3]. The benefit of drain
placement following cSDH evacuation has been proven by this
study. In our department, like in North America [4], such practice
was established long ago without previous evidence-based data.
Independent predictors of cSDH recurrence have been
identified in several articles. However they mostly consist of
non-modifiable factors such as hematoma characteristics and co-
morbidities [5,6,7,8]. They are valuable for counselling patients
and their families but are of less importance for the modification of
treatment process. Other set of articles recently pointed at the two
burr hole craniostomy as a procedure of choice for cSDH
evacuation, by this way authorizing surgical approach used in our
department for years [9,10,11,12,13,14].
In contrast to patient-related factors and the surgical procedure
itself, the management of patients following surgery for cSDH has
been infrequently subjected to detailed analysis. However it can be
an important factor warranting further progress in improvement
of treatment results. Since, to the best of our knowledge, the
influence of intensity of intravenous fluid administration during
post-operative period on clinical course of patients operated due to
cSDH was not evaluated till now, we included it into analysis.
Methods
Objective
The evaluation of factors influencing outcomes in patients with
cSDH treated surgically including those related to the post-
operative care such as intravenous fluid administration (IFA).
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A total of 45 patients with cSDH were operated in our
department via burr-hole craniostomy within one calendar year.
Patients’ age ranged from 24 to 86 (mean 66) yrs. The ratio of men
to women was 2:1. On admission patients were in good
neurological condition 213–15 pts GCS. Hemiparesis did not
exceed 4 pts Lovett scale. Bilateral haematomas were present in 3
(7%) patients. Abnormal coagulation profile was diagnosed in
another 6 (14%) patients – they were operated only after profile
correction. Hematocrit and Natrium values of all patients were
within normal range (39–50% and 136–143 mmol/l, respectively).
Description of procedures
Patients with cSDH were routinely operated in our department
as emergency cases, without any delay. The surgeries were
performed under general anaesthesia, however since it is very
short, the kind of anaesthesia should not influence the fluid intake
by patients in the post-operative period. Downward drainage was
left in hematoma cavity for a one day. Drainage placement was
abandoned in one patient only, because of intra-operative brain
re-expansion.
The intravenous fluid therapy consisted of crystalloids. Fluids
were infused slowly, at a rate of 125 ml/h. Between drips patients
were mobilized. Beside intravenous fluid administration patients
had free access to food and drink. Patients were kept in hospital
until surgical wound got healed. Usually it was 7 days following
surgery and 10 days after re-operation. Head CT scan and
evaluation of neurological status were performed in all patients at
discharge from hospital.
Statistical methods
Independent variables (factors) selected for the analysis were
related to various aspects of therapy (Table 1). Two dependent
variables were chosen as a measure of clinical course: the rate of
hematoma recurrence (RHR) and neurological status at discharge
from hospital expressed in points of Glasgow Outcome Scale
(GOS). Then both: independent and dependent variables were
subjected to correlation analyses using Pearson correlation
coefficients (PROC CORR, SAS, version 9.2) to exclude
redundancy.
Univariate and multivariate regression analysis has been
performed using maximum likelihood (ML) approach (PROC
LOGISTIC, SAS, version 9.2). If quasi-complete separation of
data points were detected, Firth penalized maximum likelihood
(FPML) method has been employed. Likelihood ratio (LR) has
been used for testing global null hypothesis, with significance level
set at 0.05. Backward selection process during multivariate
regression analysis has been performed manually as current
version of SAS does still not support Firth bias correction method.
Prior to backward selection initiation the results of independent
variable correlation has been analysed in detail to exclude similar
and highly interdependent factors disturbing the process of
multivariate regression.
Significant influence of IFA on clinical course of patients has
been found. It warranted supplementary analysis of this factor.
The volume of ca. 2000 ml/day is considered as a daily water
demand thus the number of postoperative days when fluids were
administered in at least such amount has been added to the
analysis and named as full fluids (FF). It enables to shape the easy
to memorize for clinicians ‘‘take home message’’, beyond the
rather difficult to apply in daily practice, results of multivariate
regression analysis. Finally patients were divided into two groups
with regard to FF length: one with administration of at least
2000 ml/day over at least 3 postoperative days (high-dose fluid
administration, HDFA) and the other with administration of at
least 2000 ml/day for a period shorter than 3 days postoperatively
(low-dose fluid administration, LDFA).
Ethical issues
Since this is retrospective analysis of conventionally treated
patients, without disclosure of their identity, no ethics approval
from Institutional Review Board was necessary. The amount of
intravenous fluids administered to patients depended on prefer-
ence of physician taking care in post-operative period. Some
physicians routinely withdrew drips within 1–2 days, while others
routinely kept them over several days. Such situation takes place as
no medical standard regarding the post-operative fluid therapy for
patients with cSDH was set yet. Informed consent for surgery was
obtained from each patient. Since it is not prospective study no
consent for inclusion into the study was possible to receive at all. In
fact, retrospective analysis of treatment results in many neurosur-
gical conditions is a part of clinical duties in our department, and
only outstanding findings are prepared for publication.
Results
Hematoma recurrence with subsequent evacuation occurred in
7 (15%) patients. At discharge from hospital 42 patients
experienced good recovery (5 pts GOS). Moderate disability
(4 pts GOS) was observed in remained 3 patients due to residual
neurological deficit which was present preoperatively. Hematoma
recurrence did not worse an outcome. All patients subjected to re-
operation recovered satisfactorily. No complication of general
anaesthesia and severe medical consequences during postoperative
period were observed.
No correlation between dependent variables has been found
(phi=20.11, p=0.45). The interdependence of independent
variables has been revealed in several cases only (Table S1).
Based on that Markwalder scale has been excluded from backward
multivariate regression due to high correlation with other more
detailed indicators of neurological status on admission to hospital.
Univariate regression analysis revealed that length of IFA after
surgery influenced both dependent variables: RHR (p=0.045) and
GOS (p=0.023) (Table 2). The reduction of period of post-
operative IFA increased the risk of hematoma recurrence and was
related to worse outcome at discharge from hospital. No one of
other independent variables such as: age, gender, neurological
status on admission to hospital, laboratory exams, hematoma
characteristic and the level of surgeon competence influenced the
rate of hematoma recurrence. Patient outcome (GOS) has not also
been affected by above factors except of Natrium level in serum.
Multivariate regression performed by backward elimination
method confirmed that IFA is a sole independent factor
influencing RHR (Table 3). GOS has been affected by a
combination of 2 factors: IFA and Na (Table 4).
Supplementary analysis revealed that FF is also significant
predictor of RHR (p=0.036). Dichotomous division of patients
with relation to FF revealed that HDFA group experienced lower
rate of hematoma recurrence than LDFA one (p=0.031) (Table 5).
Discussion
We report on the regression analysis of cSDH treatment.
Relatively homogenous group of patients was presented in this
study with regard to good neurological status on admission to
hospital. It probably determined favourable outcome at discharge.
Despite that the rate of hematoma recurrence was significant.
Intravenous Fluids for Chronic Subdural Hematoma
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Therapy aspect Independent variable Units of variable measure Variable description
Patient demographics Age years Patients’ age on admission to hospital
Gender male vs female Patients’ gender
Patient neurological status on
admission to hospital
GCS points Glasgow Coma Scale (GCS)
Markwalder points Markwalder scale
ND YES vs. NOT Presence of neurological deficit
Laboratory tests on admission
to hospital
Na mmol/l Level of Natrium in serum
Hct Percents (%) Value of Hematocrit in blood
ACP YES vs. NOT Abnormal coagulation profile
Hematoma characteristic HT millimetres Thickness of hematoma
BLH YES vs. NOT Bilateral hematoma
Treatment characteristic Competence (S vs T) The level of surgeon competence
(specialist or on-training). However all
surgeries were supervised by attending
neurosurgeons.
IFA days The number of days after surgery when
fluids were administered intravenously
doi:10.1371/journal.pone.0035634.t001
Table 2. Univariate regression analysis.
Independent
variable
Dependent
variable Odds ratio estimates
Likelihood ratio
(chi-square) P value
Point estimate
95% Wald
confidence limits
Age RHR 0.983 0.935 1.033 0.442 0.506
GOS 1.112 0.950 1.303 3.110 0.078
Gender RHR 2.100 0.399 11.066 0.742 0.389
GOS 5.636 0.464 68.464 1.981 0.159
GCS RHR (F) 0.849 0.227 3.175 0.061 0.805
GOS 0.668 0.097 4.619 0.164 0.689
Markwalder RHR 1.249 0.242 6.455 0.073 0.787
GOS (F) 3.102 0.167 57.700 0.736 0.391
ND RHR 0.833 0.164 4.239 0.048 0.826
GOS (F) 0.143 0.006 3.149 2.339 0.126
Na RHR 1.064 0.663 1.708 0.066 0.797
GOS 2.285 0.924 5.655 4.199 0.040
Hct RHR 1.124 0.916 1.380 1.232 0.267
GOS 0.798 0.542 1.175 1.471 0.225
ACP RHR (F) 3.001 0.121 74.356 0.676 0.411
GOS 0.270 0.021 3.552 0.860 0.354
HT RHR 0.982 0.884 1.091 0.118 0.732
GOS 0.948 0.802 1.120 0.428 0.513
BLH RHR (F) 1.478 0.044 49.592 0.068 0.794
GOS (F) 0.620 0.017 22.595 0.080 0.777
Competence RHR 1.458 0.249 8.537 0.181 0.670
GOS 1.111 0.093 13.295 0.007 0.933
IFA RHR 0.599 0.343 1.051 4.021 0.045
GOS 0.358 0.118 1.093 5.168 0.023
Significant values are featured with bold font. Abbreviations: GCS: Glasgow Coma Scale, ND: Neurological Deficit, Na: Natrium, Hct: Hematocrit, ACP: abnormal
coagulation profile, HT: Thickness of Hematoma, BLH: Bilateral Hematoma, IFA: Intravenous Fluid Administration, RHR: Rate of Hematoma Recurrence, GOS: Glasgow
Outcome Scale.
doi:10.1371/journal.pone.0035634.t002
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intravenous fluid administration during post-operative period on
the clinical course of patients with cSDH. The role of appropriate
hydration of patients following more complex diseases such as
subarachnoid haemorrhage is well recognized [15]. However this
issue was not raised in literature in the context of cSDH which is
simpler entity, but appropriate fluid delivery may facilitate brain
re-expansion thus avoiding hematoma recurrence and accelerating
patient recovery.
As fluid therapy can not be continued endlessly the direct
inference from multivariate regression analysis is rather imprac-
tical. Thus we divided patients post hoc into 2 groups with regard
to intensity of fluid therapy. Based on those results we feel to be
entitled to recommend administration of at least 2000 ml per 3
days post-operatively to decrease the risk of hematoma recurrence.
Additionally, in our opinion fluid therapy should be included in
forthcoming investigations focused on cSDH treatment. The
application of technical advances such as pulse dye densitometry
for monitoring of fluid therapy may contribute to set a closer link
between patient hydration status and the clinical course in this
disorder [16]. Data accumulation might bring stronger argument
and further refinements of fluid therapy, by this way give reasons
for controlled randomized trial initiation to establish an evidence–
based data to improve further the management of patients with
cSDH.
Post-operative period in patients with cSDH has been
infrequently addressed by clinical researchers. Only recently it
was shown that bed rest in horizontal position following surgery
positively influenced clinical course [17]. In other study head
elevation by 30 degrees did not worse outcome and recurrence
rate in comparison to above strict regime [18]. Theoretically, bed
rest may be efficient by facilitation of brain re-expansion. Opposite
approach emphasized the value of patient early mobilization post-
operatively [19]. It decreased medical complications while not
increasing the rate of hematoma recurrence. Our approach based
on intensive fluid therapy not only may stimulate brain re-
expansion but also enables early mobilization of patients between
drips. By this way intravenous fluid administration may constitute
a golden mean giving an advantage of bed rest and early
mobilization at the same time.
The other finding of this study was that higher values of
Natrium in serum of patients on admission to hospital was related
to worse outcome at discharge from hospital. However on the
basis of this study it is difficult to explain the reason for that,
especially as the levels of Natrium were within normal range. Till
now the results of laboratory examinations were not included into
analyses of cSDH treatment and if this factor is to be considered in
future investigations it may also shed more light on the significance
of Natrium level for therapy of patients with cSDH.
The influence of level of surgeon competence might be
embarrassing and it is rarely subjected to analysis. As burr hole
craniostomy is frequently the first surgical procedure on the long
route to neurosurgical mastership it is important to evaluate
whether such training scheme does not harm patients. Patients
included in this study were operated by 12 various physicians (5
specialists and 7 trainees). Neither influence of particular physician
(data not shown) nor its level of competence (specialist vs trainee,
p.0.05) on the clinical course of patients with cSDH has been
shown. One published series of cSDH treatment by residents was
also comparable to other major series reported in literature [20].
Thus there is no advantage of specialist hand virtuosity and
patients may equally benefit from trainee craft. Obviously each
surgery was supervised by an attending neurosurgeon.
Limitations
However we are aware that conclusions drawn from this study
are limited due to some weaknesses such as retrospective
approach, relatively small group of patients, no information on
loculations, CT-imaged density and co-morbidities etc., we believe
that this work is worth to be published as new aspect of cSDH
treatment has been shown.
Conclusions
We hypothesize that post-operative care might be a source of
further improvement of cSDH therapy and it requires more
Table 3. Multivariate regression analysis: summary of
backward independent variable elimination process for
dependent variable RHR.
Step
Effect
removed DF Number In
Wald Chi-
square Pr.Chisq
1 BLH 1 10 0.0009 0.9762
2 ACP 1 9 0.0024 0.9607
3 ND 1 8 0.1013 0.7503
4 Na 1 7 0.2953 0.5869
5 Age 1 6 0.2595 0.6105
6 GCS 1 5 0.6064 0.4361
7 Gender 1 4 0.4600 0.4976
8 Competence 1 3 1.5441 0.2140
9 HT 1 2 0.8610 0.3535
10 Hct 1 1 1.0966 0.2950
Effect IFA remained in model; LR=4.021; p=0.0449.
Significant values are featured with bold font. Abbreviations: GCS: Glasgow
Coma Scale, ND: Neurological Deficit, Na: Natrium, Hct: Hematocrit, ACP:
abnormal coagulation profile, HT: Thickness of Hematoma, BLH: Bilateral
Hematoma, IFA: Intravenous Fluid Administration, RHR: Rate of Hematoma
Recurrence.
doi:10.1371/journal.pone.0035634.t003
Table 4. Multivariate regression analysis: summary of
backward independent variable elimination process for
dependent variable GOS.
Step
Effect
removed DF
Number
In
Wald Chi-
square Pr.Chisq
1 GCS 1 10 0.0012 0.9725
2 Competence 1 9 0.0033 0.9542
3 ACP 1 8 0.0000 0.9946
4 Age 1 7 0.0109 0.9169
5 Hct 1 6 0.0186 0.8915
6 HT 1 5 0.0084 0.9270
7 BLH 1 4 0.0515 0.8204
8 Gender 1 3 0.3093 0.5781
9 ND 1 2 0.0210 0.8848
Combination of effects IFA and Na remained in model; LR=9.7944; p=0.0075.
Significant values are featured with bold font. Abbreviations: GCS: Glasgow
Coma Scale, ND: Neurological Deficit, Na: Natrium, Hct: Hematocrit, ACP:
abnormal coagulation profile, HT: Thickness of Hematoma, BLH: Bilateral
Hematoma, IFA: Intravenous Fluid Administration, GOS: Glasgow Outcome
Scale.
doi:10.1371/journal.pone.0035634.t004
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Natrium level may prevent hematoma recurrence and accelerate
patient recovery.
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